https://orcid.org/0000-0003-4691-2200
Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yared Abate Getahun, Destaw Asfaw Ali, Bihonegn Wodajnew Taye & Yismaw Alemie Alemayehu. (2022) Multidrug-Resistant Microbial Therapy Using Antimicrobial Peptides and the CRISPR/Cas9 System. Veterinary Medicine: Research and Reports 13, pages 173-190.
Read now
Read now
Aditi Singh, Sudhakar Padmesh, Manish Dwivedi & Irena Kostova. (2022) How Good are Bacteriophages as an Alternative Therapy to Mitigate Biofilms of Nosocomial Infections. Infection and Drug Resistance 15, pages 503-532.
Read now
Read now
Majid Taati Moghadam, Amin Khoshbayan, Zahra Chegini, Iman Farahani & Aref Shariati. (2020) Bacteriophages, a New Therapeutic Solution for Inhibiting Multidrug-Resistant Bacteria Causing Wound Infection: Lesson from Animal Models and Clinical Trials. Drug Design, Development and Therapy 14, pages 1867-1883.
Read now
Read now
Mahsa Shahbandeh, Majid Taati Moghadam, Reza Mirnejad, Shiva Mirkalantari & Mehrnaz Mirzaei. (2020) The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa. International Journal of Nanomedicine 15, pages 6905-6916.
Read now
Read now
Articles from other publishers (49)
Kushagri Singh, Asim Biswas, Alok Kumar Chakrabarti & Shanta Dutta. (2023) Phage Therapy as a Protective Tool Against Pathogenic Bacteria: How Far
We Are?. Current Pharmaceutical Biotechnology 24:10, pages 1277-1290.
Crossref
Crossref
Jiawei Wang, Debadyuti Ghosh & Mohammed Maniruzzaman. (2023) Using bugs as drugs: Administration of bacteria-related microbes to fight cancer. Advanced Drug Delivery Reviews 197, pages 114825.
Crossref
Crossref
Hong Liu, Milad Kheirvari & Ebenezer Tumban. (2023) Potential Applications of Thermophilic Bacteriophages in One Health. International Journal of Molecular Sciences 24:9, pages 8222.
Crossref
Crossref
Fatemeh Shafigh Kheljan, Farzam Sheikhzadeh Hesari, Mohammad Sadegh Aminifazl, Mikael Skurnik, Sophio Gholadze & Gholamreza Zarrini. (2023) Design of Phage-Cocktail–Containing Hydrogel for the Treatment of Pseudomonas aeruginosa–Infected Wounds. Viruses 15:3, pages 803.
Crossref
Crossref
Fabio Sallustio, Angela Picerno, Francesca Montenegro, Maria Teresa Cimmarusti, Vincenzo Di Leo & Loreto Gesualdo. (2023) The Human Virome and Its Crosslink with Glomerulonephritis and IgA Nephropathy. International Journal of Molecular Sciences 24:4, pages 3897.
Crossref
Crossref
Li Huang, Siyi Huang, Lingli Jiang, Jingjie Tan, Xueping Yan, Chunmei Gou, Xinchong Chen, Lijuan Xiang, Dali Wang, Guangtao Huang, Yixin Zhang & Chengliang Deng. (2023) Characterisation and sequencing of the novel phage Abp95, which is effective against multi-genotypes of carbapenem-resistant Acinetobacter baumannii. Scientific Reports 13:1.
Crossref
Crossref
Yining Zhao, Luozhu Feng, Beibei Zhou, Xiaodong Zhang, Zhuocheng Yao, Lingbo Wang, Zhongyong Wang, Tieli Zhou & Lijiang Chen. (2023) A newly isolated bacteriophage vB8388 and its synergistic effect with aminoglycosides against multi-drug resistant Klebsiella oxytoca strain FK-8388. Microbial Pathogenesis 174, pages 105906.
Crossref
Crossref
Georgia Mitropoulou, Angela Koutsokera, Chantal Csajka, Sylvain Blanchon, Alain Sauty, Jean-Francois Brunet, Christophe von Garnier, Grégory Resch & Benoit Guery. (2022) Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations. European Respiratory Review 31:166, pages 220121.
Crossref
Crossref
Yujing Tan, Jianhui Su, Minghui Fu, Hongmei Zhang & Haiyan Zeng. (2022) Recent Advances in Phage-Based Therapeutics for Multi-Drug Resistant Acinetobacter baumannii. Bioengineering 10:1, pages 35.
Crossref
Crossref
Aref Shariati, Maniya Arshadi, Mohammad Ali Khosrojerdi, Mostafa Abedinzadeh, Mahsa Ganjalishahi, Abbas Maleki, Mohsen Heidary & Saeed Khoshnood. (2022) The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. Frontiers in Public Health 10.
Crossref
Crossref
Samman Munir, Mohsin Khurshid, Matloob Ahmad, Usman Ali Ashfaq & Magdi E. A. Zaki. (2022) Exploring the Antimicrobial and Pharmacological Potential of NF22 as a Potent Inhibitor of E. coli DNA Gyrase: An In Vitro and In Silico Study. Pharmaceutics 14:12, pages 2768.
Crossref
Crossref
Ngozi Joannes Anyaegbunam, Chijioke Chinedu Anekpo, Zikora Kizito Glory Anyaegbunam, Yandev Doowuese, Chinwe Blessing Chinaka, Oluchi Joannes Odo, Hyelnaya Cletus Sharndama, Onyekachi Philomena Okeke & Ifeanyi Elibe Mba. (2022) The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects. Microbiological Research 264, pages 127155.
Crossref
Crossref
Badrinath Vengarai Jagannathan, Megan Dakoske & Paul Priyesh Vijayakumar. (2022) Bacteriophage-mediated control of pre- and post-harvest produce quality and safety. LWT 169, pages 113912.
Crossref
Crossref
Rima Fanaei Pirlar, Jeroen Wagemans, Fabian Kunisch, Rob Lavigne, Andrej Trampuz & Mercedes Gonzalez Moreno. (2022) Novel Stenotrophomonas maltophilia Bacteriophage as Potential Therapeutic Agent. Pharmaceutics 14:10, pages 2216.
Crossref
Crossref
Fei Li, Fengjuan Tian, Amina Nazir, Shujing Sui, Mengzhe Li, Dongxiao Cheng, Siqin Nong, Azam Ali, Mohib-Ullah KaKar, Lu Li, Qiang Feng & Yigang Tong. (2022) Isolation and genomic characterization of a novel Autographiviridae bacteriophage IME184 with lytic activity against Klebsiella pneumoniae. Virus Research 319, pages 198873.
Crossref
Crossref
Yongjie Zhao, Shengwen Shang, Ya Song, Tianyue Li, Mingliang Han, Yuexuan Qin, Meili Wei, Jun Xi & Bikui Tang. (2022) Sulforaphane kills Mycobacterium tuberculosis H37Ra and Mycobacterium smegmatis mc2155 through a reactive oxygen species dependent mechanism. Journal of Microbiology 60:11, pages 1095-1105.
Crossref
Crossref
Md Abu Sayem Khan & Sabita Rezwana Rahman. (2022) Use of Phages to Treat Antimicrobial-Resistant Salmonella Infections in Poultry. Veterinary Sciences 9:8, pages 438.
Crossref
Crossref
Ahmed Amin Akhmouch, Soukayna Hriouech, Aouatef Mzabi, Mariam Tanghort, Hanane Chefchaou, Adnane Remmal & Najat Chami. (2022) Synergistic Action of AMX Associated with 1,8-Cineole and Its Effect on the ESBL Enzymatic Resistance Mechanism. Antibiotics 11:8, pages 1002.
Crossref
Crossref
Jiawei Bai, Feiyang Zhang, Shuang Liang, Qiao Chen, Wei Wang, Ying Wang, Alberto J. Martín-Rodríguez, Åsa Sjöling, Renjing Hu & Yingshun Zhou. (2022) Isolation and Characterization of vB_kpnM_17-11, a Novel Phage Efficient Against Carbapenem-Resistant Klebsiella pneumoniae. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Yanping Li, Suresh Kumar, Lihu Zhang & Hongjie Wu. (2022) Klebsiella pneumonia and Its Antibiotic Resistance: A Bibliometric Analysis. BioMed Research International 2022, pages 1-10.
Crossref
Crossref
Greater Kayode Oyejobi, Waidi Folorunso Sule, Sunday Babatunde Akinde, Fazal Mehmood Khan & Faith Ogolla. (2022) Multidrug-resistant enteric bacteria in Nigeria and potential use of bacteriophages as biocontrol. Science of The Total Environment 824, pages 153842.
Crossref
Crossref
Majid Taati Moghadam, Ali Mojtahedi, Mehrdad Moosazadeh Moghaddam, Mahdi Fasihi-Ramandi & Reza Mirnejad. (2022) Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria. Applied Microbiology and Biotechnology 106:11, pages 3879-3893.
Crossref
Crossref
Pavel V. Tkachev, Ivan M. Pchelin, Daniil V. Azarov, Andrey N. Gorshkov, Olga V. Shamova, Alexander V. Dmitriev & Artemiy E. Goncharov. (2022) Two Novel Lytic Bacteriophages Infecting Enterococcus spp. Are Promising Candidates for Targeted Antibacterial Therapy. Viruses 14:4, pages 831.
Crossref
Crossref
Anna Zyman, Andrzej Górski & Ryszard Międzybrodzki. (2022) Phage therapy of wound-associated infections. Folia Microbiologica 67:2, pages 193-201.
Crossref
Crossref
Mohammed Fatih Rasul, Bashdar Mahmud Hussen, Abbas Salihi, Bnar Saleh Ismael, Paywast Jamal Jalal, Anna Zanichelli, Elena Jamali, Aria Baniahmad, Soudeh Ghafouri-Fard, Abbas Basiri & Mohammad Taheri. (2022) Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy. Molecular Cancer 21:1.
Crossref
Crossref
Tingting Hong, Xing Liu, Qi Zhou, Yilian Liu, Jing Guo, Wenhu Zhou, Songwen Tan & Zhiqiang Cai. (2021) What the Microscale Systems “See” In Biological Assemblies: Cells and Viruses?. Analytical Chemistry 94:1, pages 59-74.
Crossref
Crossref
Seyed Mahmoud Amin Marashi, Farhad Nikkhahi, Dariush Hamedi & Gholamhassan Shahbazi. (2022)
Isolation, Characterization and
in vitro
Evaluation of Specific Bacteriophages Targeting Extensive Drug Resistance Strains of
Pseudomonas aeruginosa
Isolated from Septic Burn Wounds
. Infection & Chemotherapy 54:1, pages 153.
Crossref
Crossref
Atif Khan, T. Subba Rao & Hiren M. Joshi. (2022) Phage therapy in the Covid-19 era: Advantages over antibiotics. Current Research in Microbial Sciences 3, pages 100115.
Crossref
Crossref
Ishika Verma, Rika Semalty & Reema Gabrani. 2022. Antimicrobial Resistance. Antimicrobial Resistance
233
252
.
Rajni Kaur & Nidhi Sethi. 2022. Emerging Modalities in Mitigation of Antimicrobial Resistance. Emerging Modalities in Mitigation of Antimicrobial Resistance
357
374
.
Guanxiang Liang, Ana Georgina Cobián-Güemes, Lindsey Albenberg & Frederic Bushman. (2021) The gut virome in inflammatory bowel diseases. Current Opinion in Virology 51, pages 190-198.
Crossref
Crossref
Seyed Mohammad Mousavi, Sajad Babakhani, Leila Moradi, Saina Karami, Mahsa Shahbandeh, Maryam Mirshekar, Samane Mohebi & Majid Taati Moghadam. (2021) Bacteriophage as a Novel Therapeutic Weapon for Killing Colistin-Resistant Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Bacteria. Current Microbiology 78:12, pages 4023-4036.
Crossref
Crossref
Kanika Bhargava, Gopal Nath, Amit Bhargava, G. K. Aseri & Neelam Jain. (2021) Phage therapeutics: from promises to practices and prospectives. Applied Microbiology and Biotechnology 105:24, pages 9047-9067.
Crossref
Crossref
Majid Taati MoghadamMehrnaz MirzaeiMozhdeh Fazel Tehrani MoghaddamSajad BabakhaniOmid YeganehSajad AsgharzadehHamed Eraghiye FarahaniShahla Shahbazi. (2021)
The Challenge of Global Emergence of Novel Colistin-Resistant
Escherichia coli
ST131
. Microbial Drug Resistance 27:11, pages 1513-1524.
Crossref
Crossref
Jin-Sun Lee, Gyeong-Hwuii Kim, Jaegon Kim, Tae-Hyun Lim, Yongwon Yoon & Sung-Sik Yoon. (2021)
Large-Scale Production of
Cronobacter sakazakii
Bacteriophage Φ CS01 in Bioreactors via a Two-Stage Self-Cycling Process
. Journal of Microbiology and Biotechnology 31:10, pages 1430-1437.
Crossref
Crossref
Guanxiang Liang & Frederic D. Bushman. (2021) The human virome: assembly, composition and host interactions. Nature Reviews Microbiology 19:8, pages 514-527.
Crossref
Crossref
Klaudia T. Angula, Lesetja J. Legoabe & Richard M. Beteck. (2021) Chemical Classes Presenting Novel Antituberculosis Agents Currently in Different Phases of Drug Development: A 2010–2020 Review. Pharmaceuticals 14:5, pages 461.
Crossref
Crossref
Zeleke Digafie, Yadessa Melaku, Zerihun Belay & Rajalakshmanan Eswaramoorthy. (2021) Synthesis, Antibacterial, Antioxidant, and Molecular Modeling Studies of Novel [2,3′-Biquinoline]-4-Carboxylic Acid and Quinoline-3-Carbaldehyde Analogs. Journal of Chemistry 2021, pages 1-17.
Crossref
Crossref
Zahra Chegini, Amin Khoshbayan, Soheil Vesal, Alireza Moradabadi, Ali Hashemi & Aref Shariati. (2021) Bacteriophage therapy for inhibition of multi drug‐resistant uropathogenic bacteria: a narrative review. Annals of Clinical Microbiology and Antimicrobials 20:1.
Crossref
Crossref
Sada Raza, Kinga Matuła, Sylwia Karoń & Jan Paczesny. (2021) Resistance and Adaptation of Bacteria to Non-Antibiotic Antibacterial Agents: Physical Stressors, Nanoparticles, and Bacteriophages. Antibiotics 10:4, pages 435.
Crossref
Crossref
Aliaa Ali El Shamy, Zainab Zakaria, Mahmoud M. Tolba, Nermeen Salah Eldin, Al-Taher Rabea, Mahmoud M. Tawfick & Hebatallah A. Nasser. (2021) AmpC β-Lactamase Variable Expression in Common Multidrug-Resistant Nosocomial Bacterial Pathogens from a Tertiary Hospital in Cairo, Egypt. International Journal of Microbiology 2021, pages 1-10.
Crossref
Crossref
Ome Kalsoom Afridi, Johar Ali & Jeong Ho Chang. (2021) Fecal Microbiome and Resistome Profiling of Healthy and Diseased Pakistani Individuals Using Next-Generation Sequencing. Microorganisms 9:3, pages 616.
Crossref
Crossref
Safia Samir. (2021) Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics. Recent Patents on Biotechnology 15:1, pages 25-33.
Crossref
Crossref
Ahmad Y. Hassan, Janet T. Lin, Nicole Ricker & Hany Anany. (2021) The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications?. Pharmaceuticals 14:3, pages 199.
Crossref
Crossref
Shamim I. Ahmad. 2021. Human Viruses: Diseases, Treatments and Vaccines. Human Viruses: Diseases, Treatments and Vaccines
663
692
.
Xin Chi, Calvin Q. Pan, Shunai Liu, Danying Cheng, Ziwen Cao & Huichun Xing. (2020) Regulating Intestinal Microbiota in the Prevention and Treatment of Alcohol-Related Liver Disease. Canadian Journal of Gastroenterology and Hepatology 2020, pages 1-10.
Crossref
Crossref
Hedmon Okella, John J. Georrge, Sylvester Ochwo, Christian Ndekezi, Kevin Tindo Koffi, Jacqueline Aber, Clement Olusoji Ajayi, Fatoumata Gnine Fofana, Hilda Ikiriza, Andrew G. Mtewa, Joseph Nkamwesiga, Christian Bernard Bakwo Bassogog, Charles Drago Kato & Patrick Engeu Ogwang. (2020) New Putative Antimicrobial Candidates: In silico Design of Fish-Derived Antibacterial Peptide-Motifs. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
Yang Liu, Ying Cui, Liyan Lu, Yufeng Gong, Wen Han & Guishun Piao. (2020) Natural indole‐containing alkaloids and their antibacterial activities. Archiv der Pharmazie 353:10, pages 2000120.
Crossref
Crossref
Milad Mohammadyari, Ziba Mozaffari & Bahareh Rahimian Zarif. (2020) Study of synergistic effect of copper and silver nanoparticles with 10% benzalkonium chloride on Pseudomonas aeruginosa. Gene Reports 20, pages 100743.
Crossref
Crossref